NCT03548792

Brief Summary

A randomized controlled clinical and RSA study, comparing 2 knee implants:

  • Helse Bergen HF, Kysthospitalet i Hagavik (KIH)
  • Helse Førde HF, Lærdal sykehus
  • Helse Bergen HF, Haukeland universitetssykehus (HUS) 1-3 surgeons in each hospital will perform the operations. There will be 80 patients in the 2 groups; a total of 160 study patients will be included. 30 in each group will be included for RSA. Radiostereometric analysis (RSA) will be used to measure migration and subsidence of components in addition to regular radiographs. 3 different knee scoring systems will be used to evaluate satisfaction and function. An activity monitor will be used to assess real-life physical behavior and walking speed to assess objectively measured mobility. Data from the Norwegian Arthroplasty Register will be used to investigate the risk of revision.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P75+ for not_applicable

Timeline
39mo left

Started May 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
May 2017Jul 2029

Study Start

First participant enrolled

May 18, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

May 24, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 7, 2018

Completed
11.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2029

Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

12.1 years

First QC Date

May 24, 2018

Last Update Submit

September 12, 2025

Conditions

Keywords

Arthroplasty Knee

Outcome Measures

Primary Outcomes (1)

  • FJS12

    Forgotten joint score 12

    10 year follow up

Secondary Outcomes (6)

  • KSS

    10 years

  • KOOS

    10 years

  • EQ5D

    10 years

  • Revision risk

    10 years

  • Walking speed

    10 years

  • +1 more secondary outcomes

Other Outcomes (2)

  • Radiographs

    10 years

  • RSA

    10 years

Study Arms (2)

RSA radiostereometric analysis

OTHER

30 patients in each Group Persona or Nexgen will receive tantalus beads to achieve RSA analysis comparing micromevements in radiographs.

Radiation: RSA radiostereometric analysis

Clinical comparison

OTHER

Clinical comarison using different patient reported outcome measures and objective measures (ActivePAL, walking speed)

Behavioral: Clinical comparison

Interventions

Tantalum beads will be inserted in polyethylene Component and in bone to assess micromotion of Components in radiographs

RSA radiostereometric analysis

ActivePAL, walking speed

Clinical comparison

Eligibility Criteria

AgeUp to 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients under the age of 80
  • Both gender
  • Primary osteoarthritis
  • BMI ≤ 35

You may not qualify if:

  • Patient over the age of 80
  • Other diagnoses than primary osteoarthritis
  • BMI \>35
  • ASA 4 patients (American Society of Anesthesiologists)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helse Bergen, Kysthospitalet i Hagavik

Hagavik, 5217, Norway

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Ove Furnes, Professor

    Helse Bergen, Norwegian Arthroplasty Register

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of knee surgery

Study Record Dates

First Submitted

May 24, 2018

First Posted

June 7, 2018

Study Start

May 18, 2017

Primary Completion (Estimated)

July 5, 2029

Study Completion (Estimated)

July 5, 2029

Last Updated

September 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations